Detalhe da pesquisa
1.
Identification of CDK10 as an important determinant of resistance to endocrine therapy for breast cancer.
Cancer Cell
; 13(2): 91-104, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18242510
2.
iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53.
Nat Genet
; 38(10): 1133-41, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16964264
3.
Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response.
Nature
; 448(7157): 1063-7, 2007 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-17728759
4.
The prolyl isomerase Pin1 orchestrates p53 acetylation and dissociation from the apoptosis inhibitor iASPP.
Nat Struct Mol Biol
; 14(10): 912-20, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17906639
5.
p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis.
Cancer Cell
; 3(4): 387-402, 2003 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12726864
6.
Survival prediction and frequency of anticancer treatment in cancer patients hospitalized due to acute conditions. Role of clinical parameters and PaP score.
Support Care Cancer
; 19(11): 1823-30, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21560032
7.
Functional regulation of p73 and p63: development and cancer.
Trends Biochem Sci
; 28(12): 663-70, 2003 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-14659698
8.
Epigenetic inactivation implies independent functions for insulin-like growth factor binding protein (IGFBP)-related protein 1 and the related IGFBPL1 in inhibiting breast cancer phenotypes.
Clin Cancer Res
; 13(14): 4061-8, 2007 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17634530
9.
A phase I-II preoperative biomarker trial of fenretinide in ascitic ovarian cancer.
Cancer Epidemiol Biomarkers Prev
; 15(10): 1914-9, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17035399
10.
Gemcitabine and cisplatin in a concomitant alternating chemoradiotherapy program for locally advanced head-and-neck cancer: a pharmacology-guided schedule.
Int J Radiat Oncol Biol Phys
; 66(3): 731-7, 2006 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17011449
11.
Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativity.
Cancer Res
; 62(7): 2072-6, 2002 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11929827
12.
Coincident inactivation of 14-3-3sigma and p16INK4a is an early event in vulval squamous neoplasia.
Oncogene
; 21(12): 1876-81, 2002 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-11896620
13.
Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo.
Oncogene
; 23(19): 3328-37, 2004 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-15077186
14.
Concomitant inactivation of p53 and Chk2 in breast cancer.
Oncogene
; 21(9): 1316-24, 2002 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-11857075
15.
SERMs in chemoprevention of breast cancer.
Eur J Cancer
; 41(13): 1980-9, 2005 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-15964182
16.
Paclitaxel, cisplatin, 5-fluorouracil and radiotherapy in the management of advanced squamous cell carcinoma of the head and neck: a phase II trial.
Radiother Oncol
; 75(2): 193-6, 2005 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16086909
17.
Carboplatin and weekly paclitaxel in non-small cell lung cancer patients unfit for or pretreated with chemotherapy.
Anticancer Res
; 25(3c): 2555-9, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16080492
18.
TP53 mutations in familial breast cancer: functional aspects.
Hum Mutat
; 21(3): 301-6, 2003 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-12619116
19.
Single-agent pegylated liposomal doxorubicin (Caelix) in chemotherapy pretreated non-small cell lung cancer patients: a pilot trial.
Lung Cancer
; 35(1): 59-64, 2002 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-11750714
20.
The p53 network in head and neck cancer.
Oral Oncol
; 39(3): 222-31, 2003 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12618194